Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.
Publication
, Journal Article
Berwanger, O; Guimarães, HP; Lopes, RD
Published in: N Engl J Med
March 11, 2021
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 11, 2021
Volume
384
Issue
10
Start / End Page
975 / 976
Location
United States
Related Subject Headings
- Warfarin
- Rivaroxaban
- Mitral Valve
- Humans
- General & Internal Medicine
- Atrial Fibrillation
- Anticoagulants
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Berwanger, O., Guimarães, H. P., & Lopes, R. D. (2021). Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply. N Engl J Med, 384(10), 975–976. https://doi.org/10.1056/NEJMc2035891
Berwanger, Otavio, Helio P. Guimarães, and Renato D. Lopes. “Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.” N Engl J Med 384, no. 10 (March 11, 2021): 975–76. https://doi.org/10.1056/NEJMc2035891.
Berwanger O, Guimarães HP, Lopes RD. Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply. N Engl J Med. 2021 Mar 11;384(10):975–6.
Berwanger, Otavio, et al. “Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.” N Engl J Med, vol. 384, no. 10, Mar. 2021, pp. 975–76. Pubmed, doi:10.1056/NEJMc2035891.
Berwanger O, Guimarães HP, Lopes RD. Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply. N Engl J Med. 2021 Mar 11;384(10):975–976.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 11, 2021
Volume
384
Issue
10
Start / End Page
975 / 976
Location
United States
Related Subject Headings
- Warfarin
- Rivaroxaban
- Mitral Valve
- Humans
- General & Internal Medicine
- Atrial Fibrillation
- Anticoagulants
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences